OverviewAI-generated
Celgene is a company and funder based in Summit, United States. It was established on January 1, 1986. The organization is currently inactive.
It is recognized as part of the Sp 500 collection. Celgene is associated with the identifier grid.418722.a and the ISNI 0000 0004 0461 1802.
Synthesized by Vinony from 14 facts across 4 sources: Wikidata, Firecrawl, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Company.name
- Celgene Corporation
- Company.logo
- 150px
- Company.type
- Subsidiary
- Company.industry
- Biotechnology
- Company.foundation
- <!--
- Company.defunct
- Celgene is still listed as a significant subsidiary of BMS in its 2025 annual report -->
- Company.parent
- Bristol Myers Squibb
- Company.location
- Summit, New Jersey, U.S.
- Company.key_people
- Robert J. Hugin (executive chairman)Mark Alles (CEO)
- Company.founder
- Sol J. Barer
- Company.products
- RevlimidAbraxanePomalyst/ImnovidThalomidIdhifa
- Company.revenue
- $15.281 billion (2018)
- Company.net_income
- $4.046 billion (2018)
- Company.assets
- $35.480 billion (2018)
- Company.equity
- $6.161 billion (2018)
- Company.num_employees
- 8,852 (2018)
via Wikipedia infobox
Research organization · ROR
- Type
- Company, Funder
- Location
- Summit, United States
- Status
- Inactive
GRID grid.418722.a · ISNI 0000 0004 0461 1802
Official website
Bristol Myers Squibb - Global Biopharmaceutical Company
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
celgene.com →Link to the official site · 9,642 chars · not written by Vinony
Described at
Celgene - Wikirate, an Open ESG Data Platform
wikirate.org →Link to a page describing this subject · 2,793 chars · not written by Vinony
Wikidata facts
- Instance of
- business
- Part of
- Nasdaq-100
- Country
- United States
- Headquarters
- Summit
- Industry
- pharmaceutical industry
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.celgene.com
Show 3 more facts
- inception
- 1986-01-01
- product or material produced
- (RS)-lenalidomide
- described at URL
- wikirate.org/Celgene
Sources (6)
via Wikidata · CC0
Article · Deutsch
Celgene war ein US-amerikanisches Pharmaunternehmen, das sich auf die Herstellung von Arzneimitteln gegen Krebserkrankungen und Krankheiten des Immunsystems spezialisiert hatte. Der Sitz von Celgene befand sich in Summit, New Jersey. Das sich als biopharmaceutical company beschreibende Unternehmen beschäftigte rund 7.500 Mitarbeiter bei einem Umsatz von 15,3 Mrd. Dollar (2018). Celgene arbeitete in den Bereichen Hämatologie, Onkologie und inflammatorische Erkrankungen. Von Celgene entwickelte Immunmodulatoren, so genannte (Immunomodulatory Drugs), die ursprünglich vom Thalidomid-Molekül abgeleitet wurden, zielen auf die Bekämpfung der Krankheitsursachen, nicht auf die Symptome. Wichtigster Vertreter der IMiDs ist Lenalidomid zur Behandlung des multiplen Myeloms. Im Januar 2019 akzeptierte Celgene die Übernahme durch Bristol-Myers Squibb (BMS) für 74 Milliarden US-Dollar.
Abstract from DBpedia / Wikipedia · CC BY-SA